Healthcare Industry News: HSMN NewsFeed
News Release - September 1, 2021
Intelivation Technologies received FDA approval for the Golden Isles Pedicle Screw System(TM)SAINT SIMONS ISLAND, Ga., Sept. 1, 2021 -- (Healthcare Sales & Marketing Network) -- Intelivation Technologies, a medical device company with a cutting-edge spinal implant product portfolio announced today that they have achieved FDA 510(k) Clearance of the Golden Isles Pedicle Screw Systemô.
The Golden Isles Pedicle Screw Systemô is designed to provide immobilization and stabilization of spinal segments in skeletally mature patients in treating the lumbar and sacral spine. The system is intended for posterior, non-cervical pedicle fixation in skeletally mature patients for treating degenerative disc disease, spondylolisthesis, trauma, deformities as well as pseudoarthrosis and failed previous fusions.
President Amit Sinha remarked, "The modularity of the Golden Isles Pedicle Screw Systemô enables the surgeon greater versatility, efficiency, and visibility to achieve superior patient outcomes for the most difficult degenerative and traumatic procedures." CEO Rob Anderson added, "The simplicity of the system along with the strength of the tulip and screw interface is unsurpassed compared to other options that are currently available on the market."
Golden Isles showcases both standard and reduction tulips along with a comprehensive set of insertion and reduction instruments. The Management Team looks forward to a successful launch during the 36th Annual NASS Meeting in Boston September 29-Ocotber 2, 2021.
About Intelivation Technologies
Intelivation Technologies, dedicated to research and development, is focused on bringing game-changing products to market that make patients' lives better. For further inquiries, interested parties may email firstname.lastname@example.org.
Source: Intelivation Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.